Jane Street Group LLC grew its stake in shares of AdvanSix Inc. (NYSE:ASIX – Free Report) by 162.8% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 51,513 shares of the company’s stock after buying an additional 31,915 shares during the period. Jane Street Group LLC owned 0.19% of AdvanSix worth $1,565,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds have also recently modified their holdings of the stock. Copeland Capital Management LLC bought a new stake in shares of AdvanSix in the third quarter worth about $41,000. Point72 DIFC Ltd purchased a new position in AdvanSix during the 2nd quarter valued at approximately $34,000. Acadian Asset Management LLC bought a new stake in AdvanSix in the 2nd quarter worth approximately $36,000. Point72 Asia Singapore Pte. Ltd. purchased a new stake in shares of AdvanSix during the 2nd quarter worth approximately $51,000. Finally, Allspring Global Investments Holdings LLC bought a new position in shares of AdvanSix during the 2nd quarter valued at approximately $51,000. Hedge funds and other institutional investors own 86.39% of the company’s stock.
AdvanSix Price Performance
AdvanSix stock opened at $28.52 on Friday. The company has a debt-to-equity ratio of 0.28, a current ratio of 1.34 and a quick ratio of 0.62. The stock has a market cap of $762.37 million, a price-to-earnings ratio of 20.23 and a beta of 1.73. The firm has a 50-day moving average of $30.26 and a two-hundred day moving average of $28.16. AdvanSix Inc. has a 1 year low of $20.86 and a 1 year high of $33.00.
AdvanSix Announces Dividend
Insider Buying and Selling
In other news, Director Donald P. Newman bought 5,030 shares of the stock in a transaction on Monday, November 18th. The stock was bought at an average cost of $29.64 per share, for a total transaction of $149,089.20. Following the completion of the purchase, the director now directly owns 5,030 shares in the company, valued at approximately $149,089.20. The trade was a ∞ increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Christopher Gramm sold 2,435 shares of the firm’s stock in a transaction on Wednesday, November 6th. The stock was sold at an average price of $32.00, for a total value of $77,920.00. Following the completion of the sale, the insider now directly owns 43,463 shares of the company’s stock, valued at $1,390,816. The trade was a 5.31 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 15,369 shares of company stock valued at $474,058 over the last three months. 5.60% of the stock is owned by company insiders.
Analyst Ratings Changes
Several equities research analysts recently weighed in on ASIX shares. Piper Sandler boosted their price target on shares of AdvanSix from $35.00 to $39.00 and gave the stock an “overweight” rating in a research report on Friday, November 8th. StockNews.com upgraded shares of AdvanSix from a “hold” rating to a “buy” rating in a report on Wednesday, December 4th.
View Our Latest Analysis on AdvanSix
About AdvanSix
AdvanSix Inc engages in the manufacture and sale of polymer resins in the United States and internationally. It offers Nylon 6, a polymer resin, which is a synthetic material used to produce fibers, filaments, engineered plastics, and films. The company also provides caprolactam to manufacture polymer resins; ammonium sulfate fertilizers to distributors, farm cooperatives, and retailers; and acetone that are used in the production of adhesives, paints, coatings, solvents, herbicides, and engineered plastic resins, as well as other intermediate chemicals, including phenol, monoisopropylamine, dipropylamine, monoallylamine, alpha-methylstyrene, cyclohexanone, methyl ethyl ketoxime, acetaldehyde oxime, 2-pentanone oxime, cyclohexanol, sulfuric acid, ammonia, and carbon dioxide.
Recommended Stories
- Five stocks we like better than AdvanSix
- Investing in the High PE Growth Stocks
- Top 3 Investment Themes to Watch for in 2025
- Top Biotech Stocks: Exploring Innovation Opportunities
- Mega Buybacks in 2025: Why These 3 Leading Stocks Are Buys
- ETF Screener: Uses and Step-by-Step Guide
- AMD vs. NVIDIA: The Better Semiconductor Bet for 2025
Receive News & Ratings for AdvanSix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdvanSix and related companies with MarketBeat.com's FREE daily email newsletter.